Providing a resource (Clinical Study Coordinator) with particular expertise in effectively addressing NIH, IRB and HIPAA policies and reporting requirements concerning confidentiality, inclusion of women, children and ethnic/minority participation in clinical studies, data and safety monitoring requirements; and educational requirements for the protection of human research participants. As recognized recently, perhaps the least appreciated (but most important) barrier to translational and clinical research is the limited availability of administrative support for translation at most academic medical Centers [1; 2]. With the increasing regulatory requirements for translational and clinical research, worthwhile studies are currently being abandoned simply because of the burden of regulatory compliance [1]. The main objective of the clinical component of the Yale Liver Center is to alleviate this regulatory burden by providing this resource. This resource is of particular importance for Yale investigators since patients for clinical trials are recruited from both Yale-New Haven Medical Center and from the CT-VA Healthcare System, and each of them have separate IRBs and separate regulatory requirements. Additionally, this resource will maintain a patient, serum and DNA data and aid in the identification (through the clinical and sample databases) and recruitment of subjects for translational and clinical studies. This resource will constitute a bridge between Center basic science investigators and clinical investigators and among clinical investigators. b) Providing a resource (Biostatistician) that provides assistance to basic researchers with clinical study design, particularly for small pilot projects that are the initial step in the translational process. For established clinical investigators using the clinical component, this resource will provide consultation for clinical study/trial development particularly in establishing sample size calculations and advise regarding the most appropriate study design. c) Providing the opportunity for Center members to obtain patient data and clinical (serum, liver, DNA) samples needed for their research, including data regarding the number of patients available to evaluate study feasibility and estimated times for patient recruitment into clinical trials. This service will be provided through the Patient Database and the Serum, Liver Biopsy and DNA banks that will be maintained by the Clinical Study Coordinator.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK034989-23
Application #
7280899
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2006-09-01
Budget End
2007-08-31
Support Year
23
Fiscal Year
2006
Total Cost
$187,647
Indirect Cost
Name
Yale University
Department
Type
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Henao-Mejia, Jorge; Williams, Adam; Rongvaux, Anthony et al. (2016) Generation of Genetically Modified Mice Using the CRISPR-Cas9 Genome-Editing System. Cold Spring Harb Protoc 2016:pdb.prot090704
Nair, Shiny; Branagan, Andrew R; Liu, Jun et al. (2016) Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma. N Engl J Med 374:555-61
Collins, Kevin M; Bode, Addys; Fernandez, Robert W et al. (2016) Activity of the C. elegans egg-laying behavior circuit is controlled by competing activation and feedback inhibition. Elife 5:
Nagarajan, Arvindhan; Petersen, Max C; Nasiri, Ali R et al. (2016) MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels. Nat Commun 7:12639
Wang, Baisheng; Boeckel, Göran R; Huynh, Larry et al. (2016) Neuronal Calcium Sensor 1 Has Two Variants with Distinct Calcium Binding Characteristics. PLoS One 11:e0161414
Fiorotto, Romina; Villani, Ambra; Kourtidis, Antonis et al. (2016) The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity. Hepatology 64:2118-2134
Wree, Alexander; Mehal, Wajahat Z; Feldstein, Ariel E (2016) Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis. Semin Liver Dis 36:27-36
Sack, Jordan; Garcia-Tsao, Guadalupe (2016) Variceal Hemorrhage in a Patient With Hepatitis C Virus Cirrhosis in Whom Liver Synthetic Function had Normalized After Viral Elimination. Hepatology 63:1733-5
Nguyen, Nghia H; Yee, Brittany E; Chang, Christine et al. (2016) Tolerability and effectiveness of sofosbuvir and simeprevir in the post-transplant setting: systematic review and meta-analysis. BMJ Open Gastroenterol 3:e000066
Petersen, Max C; Madiraju, Anila K; Gassaway, Brandon M et al. (2016) Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance. J Clin Invest 126:4361-4371

Showing the most recent 10 out of 639 publications